Related Experiment Video
Updated: Aug 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
TextDTI: A Multimodal Context Representation Learning Framework for Drug-Target Interaction Prediction
Jiaqi Deng1, Senyu Tang2, Jijun Tang3
1Department of Computer Science and Software Engineering, Southern University of Science and Technology, 1068 Xueyuan Avenue, Nanshan, 518055Shenzhen, China.
Abstract:
Predicting Drug-Target Interactions (DTIs) is a crucial task in drug discovery. Recent advances in deep learning, particularly the application of Large Language Models (LLMs), have shown promise in encoding sequential information from SMILES strings and protein sequences. However, integrating these diverse modalities remains a challenge. In this paper, we propose TextDTI, a multimodal framework that simultaneously exploits sequential and structural representations. First, TextDTI utilizes Pretrained Language Models (PLMs) to generate functional description texts for proteins represented by their amino acid sequences, which includes biological functions, molecular mechanisms, and pathway involvement. Next, the generated texts and the SMILES sequences of drugs are encoded into corresponding feature representations by other separate LLMs. Third, drug and target characteristics are fused through convolutional and graph-based modules. Finally, unidentified drug-target interactions are classified using a multilayer perceptron neural network. We further enhance feature alignment through adversarial learning and contrastive loss, resulting in robust and high-performance DTI prediction. Experiments conducted on multiple data sets in both single-domain and cross-domain settings demonstrate that our model outperforms other baseline methods. The source code and data sets are available at https://github.com/xiaoyiliu-usc/TextDTI.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Quantitative Aspects of Drug-Receptor Interaction
Drug Discovery: Overview